Max Essex

Dados Biográficos

ID7496987
NOMEMax Essex
PRENOMESMax
SOBRENOMEEssex
ASSINATURAESSEX M
AFILIAÇÕESHarvard University
ORCID0000-0002-4576-7841
VERIFICADOSim
TOTAL DE OBRAS7
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR7
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2003
ANO MAIS RECENTE DE PUBLICAÇÃO2016
ÍNDICE H0

  • Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Myron S Cohen, Ying Qing Chen et al.ARTICLENew England Journal of Medicine2016

    BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. ART was then offered to all patients with HIV-1 infection (index participants). The study included more than 5 years of follow-up to assess the durability of such therapy for …

  • Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection

    Open AccessBeatriz Gilda Jegerhorn Grinsztejn, Beatriz Grinsztejn et al.ARTICLEThe Lancet Infectious Diseases2014

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Myron S Cohen, Ying Qing Chen et al.ARTICLENew England Journal of Medicine2011

    BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic m…

  • Infant Feeding Practices were not Associated with Breast Milk HIV-1 RNA Levels in a Randomized Clinical Trial in Botswana

    Open AccessRaabya Rossenkhan, Vladimir Novitsky et al.ARTICLEAIDS and Behavior2011

  • Estimating the Lost Benefits of Antiretroviral Drug Use in South Africa

    Pride Chigwedere, George R Seage et al.ARTICLEJAIDS Journal of Acquired Immune…2008

    South Africa is one of the countries most severely affected by HIV/AIDS. At the peak of the epidemic, the government, going against consensus scientific opinion, argued that HIV was not the cause of AIDS and that antiretroviral (ARV) drugs were not useful for patients and declined to accept freely donated nevirapine and grants from the Global Fund. Using modeling, we compared the number of persons who received ARVs for treatment and prevention of…

  • Identification of primary HIV-1C infection in Botswana

    Vladimir Novitsky, Elias Woldegabriel et al.ARTICLEAIDS Care2008

    Methods for identification of primary HIV infections seem increasingly important to understand pathogenesis, and to prevent transmission, which is particularly efficient during acute infection. Most current algorithms for HIV testing are based on detection of HIV antibodies and are unable to identify early infections before seroconversion. The efficiency of prospective cohorts, which is a standard approach for identifying primary HIV-1 infection,…

  • Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and Aids in Botswana

    Sheri D Weiser, Sheri Weiser et al.ARTICLEJAIDS Journal of Acquired Immune…2003

    BACKGROUND: Botswana has the highest rate of HIV infection in the world, estimated at 36% among the population aged 15-49 years. To improve antiretroviral (ARV) treatment delivery, we conducted a cross-sectional study of the social, cultural, and structural determinants of treatment adherence. METHODS: We used both qualitative and quantitative research methodologies, including questionnaires and interviews with patients receiving ARV treatment an…